Announced Tue, 14 Jul · 13:33 IST
Compliance certificate for Q1 FY27 under SEBI Regulation 74(5)
Compliance View source PDF
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹78.92
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.5+0.7+0.1+2.6+1.9+0.8————
Up moveDown movePending
AI summary
Anuh Pharma submitted a compliance certificate from its registrar Bigshare Services under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The RTA confirmed that no dematerialisation requests for equity shares were received between 1 April and 30 June 2026. This is a routine procedural filing required for listed companies with no business or financial impact.
Likely market impact
Routine procedural filing. No material impact on shareholders or stock price.